Viridian Therapeutics Inc. (VRDN)
NASDAQ · Healthcare
Viridian Therapeutics Inc. Cash on Hand 2013–2025
Viridian Therapeutics Inc. annual cash on hand history from 2013 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Viridian Therapeutics Inc. cash on hand as of December 31, 2025: 874.7M, a 21.89% increase year-over-year.
- Viridian Therapeutics Inc. cash on hand for 2025 were 874.7M, a 21.89% increase from 2024.
- Viridian Therapeutics Inc. cash on hand for 2024 were 717.6M, a 50.31% increase from 2023.
- Viridian Therapeutics Inc. cash on hand for 2023 were 477.4M, a 12.44% increase from 2022.
- Viridian Therapeutics Inc. cash on hand for 2022 were 424.6M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Viridian Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $875 |
| 2024 | $718 |
| 2023 | $477 |
| 2022 | $425 |
| 2021 | $197 |
| 2020 | $128 |
| 2019 | $27 |
| 2018 | $33 |
| 2017 | $47 |
| 2016 | $22 |
| 2015 | $21 |
| 2014 | $5 |
| 2013 | $0 |
Viridian Therapeutics Inc. Cash on Hand — FAQ
Viridian Therapeutics Inc. (VRDN) cash on hand over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VRDN's cash on hand history?
The chart and table above show Viridian Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.